María J. Redondo

Broad Institute — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

47h-index8.0kcitations346works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes and associated disorders(232), Diabetes Management and Research(213), Pancreatic function and diabetes(176), Diabetes Treatment and Management(42), Aquaculture disease management and microbiota(19)

Publications323 total

Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression
2025Open Access
Correction: Development and recalibration of a multivariable type 1 diabetes prediction model for type 1 diabetes across multiple screening studies
BMC Medicine·2025Open Access
Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression
2025Open Access
Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression
2025Open Access
Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression
Diabetes·2025Open Access
Genetic Predictors of Response to Oral Insulin for Type 1 Diabetes Prevention
2025Open Access
Genetic Predictors of Response to Oral Insulin for Type 1 Diabetes Prevention
Diabetes Care·2025Open Access
<b>A Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval</b>
2025Open Access
<b>A Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval</b>
2025Open Access
Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval
Diabetes·2025Open Access
The heterogeneity of type 1 diabetes: implications for pathogenesis, prevention, and treatment—2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum
Diabetologia·2025· 3 citedOpen Access
The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment—2024 <i>Diabetes</i>, <i>Diabetes Care</i>, and <i>Diabetologia</i> Expert Forum
Diabetes·2025· 1 citedOpen Access
The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment—2024 <i>Diabetes</i>, <i>Diabetes Care</i>, and <i>Diabetologia</i> Expert Forum
Diabetes Care·2025· 3 citedOpen Access
Contrasting Adult vs. Pediatric populations in a cohort of at risk relatives: The TrialNet Pathway to Prevention Study
2025Open Access
Contrasting Adult vs. Pediatric populations in a cohort of at risk relatives: The TrialNet Pathway to Prevention Study
2025Open Access
Contrasting Adult and Pediatric Populations in a Cohort of At-Risk Relatives in The T1D TrialNet Pathway to Prevention Study
Diabetes Care·2025· 5 cited
Development and recalibration of a multivariable type 1 diabetes prediction model for type 1 diabetes across multiple screening studies
BMC Medicine·2025· 1 citedOpen Access
The impact of ancestry on performance of type 1 diabetes genetic risk scores: high discrimination performance is maintained in African ancestry populations, but population specific thresholds may improve risk prediction
2025Open Access
Genetic Risk and Transition Through Preclinical Stages of Type 1 Diabetes
The Journal of Clinical Endocrinology & Metabolism·2025· 3 citedOpen Access
Maturity-Onset Diabetes of the Young (MODY) in a Racially/Ethnically Diverse Pediatric Population
The Journal of Clinical Endocrinology & Metabolism·2025
page 1 of 17Next →

Frequent Co-authors

George S. Eisenbarth(10), Andrea K. Steck(9), Mark A. Atkinson(8), Linda A. DiMeglio(8), Stephen E. Gitelman(8), Carla J. Greenbaum(8), Desmond Schatz(8), Jay M. Sosenko(8), Carmella Evans‐Molina(7), Peter A. Gottlieb(7), Kevan C. Herold(7), Jeffrey P. Krischer(7), Jay S. Skyler(7), Antoinette Moran(7), Richard A. Oram(6), Susan Geyer(6), Ingrid Libman(6), Alberto Pugliese(5), Brian N. Bundy(5), David A. Baidal(5)